Home›Companies›Healthcare›Converus

Converus AI, Inc.

Reimbursement software for diagnostic and genetic testing companies.

Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Converus

Converus is a private company based in Newark, Delaware, incorporated in 2026 in Delaware. It has reported $20,000 raised in one offering on Form D since September 2026. Its chief executive is Shivang Ashutosh Vaidya.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2026Sep 25, 2026$20,000of $50,000 target2$10,000Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Converus's Form D filed Sep 25, 2026.

SV
Shivang Ashutosh Vaidya
CEO and director
TM
Tania Rallo Mendez
Executive officer and director

Sources

  1. SECConverus AI, Inc. filing history
  2. CompanyConverus privacy policy